The diabetes community exercise programme plus usual care versus usual care in patients with type 2 diabetes: A randomised, two-arm, parallel, open-label trial

被引:4
|
作者
Hale, L. [1 ]
Higgs, C. [1 ]
Gray, A. R. [2 ]
Mann, J. [3 ]
Mani, R. [1 ]
Sullivan, T. [4 ]
Terry, J. [1 ]
Keen, D. [1 ]
Stokes, T. [5 ]
机构
[1] Univ Otago, Ctr Hlth Act & Rehabil Res, Sch Physiotherapy, 325 Great King St,POB 56, Dunedin 9016, New Zealand
[2] Univ Otago, Biostat Ctr, Dunedin, Otago, New Zealand
[3] Univ Otago, Dept Human Nutr, Dunedin, New Zealand
[4] Univ Otago, Dunedin Sch Med, Dept Prevent & Social Med, Dunedin, New Zealand
[5] Univ Otago, Dunedin Sch Med, Dept Gen Practice & Rural Hlth, Dunedin, New Zealand
关键词
Type; 2; diabetes; Exercise; Education; Self-management support; Ethnicity; Health equity; INTERVENTION PROGRAM; PACIFIC PATIENTS; DISEASE; MULTIMORBIDITY; PREVALENCE; PEOPLE; IMPACT; MAORI; RISK;
D O I
10.1016/j.eclinm.2022.101361
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Exercise is important in type 2 diabetes (T2D) management. Focussing on Maori and Pacific people and those from deprived circumstances, the Diabetes Community Exercise Programme (DCEP) was developed to engage people with T2D in exercise. We report the evaluation of whether being offered DCEP (plus usual care) was more effective than usual care in improving glycaemic control at 1-year. Methods A randomised, two-arm, parallel, open-label trial with blinding of outcome assessor and data analyst. Adults (age >= 35 years) with T2D recruited from two New Zealand (NZ) communities were randomised, using opaque sealed envelopes and stratified by centre with random block lengths, to DCEP or usual care. DCEP comprises twice-weekly, two-hour sessions of exercise and education over 12-weeks, followed by a twice-weekly maintenance exercise class. The primary outcome was between-group differences in mean changes of glycated haemoglobin (HbAIc) from baseline to I-year follow-up with intention-to treat analysis. This trial is registered with the Australian NZ Clinical Trials Registry (ANZCTR): ACTRN1261700162437op and is closed to new participants. Findings From 2018 - 2019, of 294 people screened, 165 (mean age 63.8, SD16.2 years, 56% female, 78.5% Euro-pean, 14% Maori, 6% Pacific, 27% most deprived) were baseline evaluated, randomised, and analysed at study end (DCEP = 83, control = 82). Multimorbidity (>= 2) and polypharmacy (>5 medications) were high (82%, 69%). We found no statistically significant between-groups differences in HbAIc (mmol/mol) change at 15 months (mean 3% higher in DCEP, 95% CI 2% lower to 8% higher, p = 0.23). Twelve-week intervention adherence was good (41% attended >80% available sessions). No adverse events were reported. Interpretation DCEP was not effective in improving glycaemic control, possibly due to insufficient exercise inten-sity. Our attendance demonstrated DCEP's cultural accessibility. DCEP might be good to engage in exercise margin-alised people with high HbiAc levels, multimorbidity, and high polypharmacy. Copyright (C) 2022 The Author(s). Published by Elsevier Ltd.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] Effects of an additional pharmaceutical care intervention versus usual care on clinical outcomes of Type 2 diabetes patients in Nigeria: A comparative study
    Adibe, Maxwell Ogochukwu
    Obinna, Udeogaranya Pactrick
    Uchenna, Igboeli Nneka
    Michael, Ubaka Chukwuemeka
    Aguwa, Cletus Nze
    SCIENTIFIC RESEARCH AND ESSAYS, 2014, 9 (12): : 548 - 556
  • [32] Cost-effectiveness of centralised and partly centralised care compared to usual care for patients with type 2 diabetes
    van der Heijden, A. A. W.
    Feenstra, T. L.
    de Bruijne, M. C.
    Baan, C. A.
    Donker, G. A.
    Dekker, J. M.
    Nijpels, G.
    DIABETOLOGIA, 2014, 57 : S444 - S445
  • [33] Advanced practice nurse intervention versus usual care for hypertension control: study protocol for an open-label randomized controlled trial
    Vay-Demouy, Juliette
    Cinaud, Alexandre
    Malka, Nathan
    Mion, Baptiste
    Kretz, Sandrine
    Lelong, Helene
    Blacher, Jacques
    TRIALS, 2023, 24 (01)
  • [34] Advanced practice nurse intervention versus usual care for hypertension control: study protocol for an open-label randomized controlled trial
    Juliette Vay-Demouy
    Alexandre Cinaud
    Nathan Malka
    Baptiste Mion
    Sandrine Kretz
    Hélène Lelong
    Jacques Blacher
    Trials, 24
  • [35] Ingestible sensor system for measuring, monitoring and enhancing adherence to antiretroviral therapy: An open-label, usual care-controlled, randomised trial
    Liu, Honghu
    Wang, Yan
    Huang, Yilan
    Xiong, Di
    Shen, Jie
    Siqueiros, Lisa
    Bala, Veenu
    Savage, George M.
    Guerrero, Mario
    Corado, Katya
    Rosen, Marc I.
    V. Fletcher, Courtney
    Daar, Eric S.
    EBIOMEDICINE, 2022, 86
  • [36] Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections
    Haak, Thomas
    ANNALS OF INTERNAL MEDICINE, 2018, 168 (07) : 525 - 526
  • [37] Glibenclamide and metfoRmin versus stAndard care in gEstational diabeteS (GRACES): a feasibility open label randomised trial
    Reynolds, Rebecca M.
    Denison, Fiona C.
    Juszczak, Ed
    Bell, Jennifer L.
    Penneycard, Jessica
    Strachan, Mark W. J.
    Lindsay, Robert S.
    Alexander, Claire I.
    Love, Corinne D. B.
    Whyte, Sonia
    Mackenzie, Fiona
    Stenson, Ben
    Norman, Jane E.
    BMC PREGNANCY AND CHILDBIRTH, 2017, 17
  • [38] Glibenclamide and metfoRmin versus stAndard care in gEstational diabeteS (GRACES): a feasibility open label randomised trial
    Rebecca M. Reynolds
    Fiona C. Denison
    Ed Juszczak
    Jennifer L. Bell
    Jessica Penneycard
    Mark W. J. Strachan
    Robert S. Lindsay
    Claire I. Alexander
    Corinne D. B. Love
    Sonia Whyte
    Fiona Mackenzie
    Ben Stenson
    Jane E. Norman
    BMC Pregnancy and Childbirth, 17
  • [39] Multifactorial Intervention on Type 2 Diabetes (MIDiab) Study: A multicenter,open-label, randomized, parallel controlled, community trial
    Wang, Yupeng
    Guan, Qingbo
    Hou, Xu
    Zhang, Xu
    Zhang, Haiqing
    Xu, Chao
    Jing, Fei
    Ma, Shizhan
    Shao, Shanshan
    Zhao, Meng
    Guo, Qingling
    Zhong, Fang
    Gao, Ling
    Zhao, Jiajun
    JOURNAL OF DIABETES, 2020, 12 (11) : 862 - 864
  • [40] Qatar Diabetes Mobile Application Trial (QDMAT): an open-label randomised controlled trial to examine the impact of using a mobile application to improve diabetes care in type 2 diabetes mellitus—a study protocol
    Noor Suleiman
    Meis Alkasem
    Zaina Al Amer
    Obada Salameh
    Noora Al-Thani
    Mohammad Khair Hamad
    Khaled Baagar
    Ibrahem Abdalhakam
    Manal Othman
    Ragae Dughmosh
    Dabia Al-Mohanadi
    Ali Al Sanousi
    Mohammed Bashir
    Odette Chagoury
    Shahrad Taheri
    Abdul-Badi Abou-Samra
    Trials, 23